image

SEC Filing Details

We are focused on the rapid design and development of new medicines based on breakthroughs in cancer research.
SEC Filing Details

Document Details

Form
EFFECT
Filing Date
November 24, 2021
Document Date
November 24, 2021
Form Description
EFFECT
Filing Group
Other
Company
Prelude Therapeutics
Issuer
PRELUDE THERAPEUTICS INC
Print Page
RSS Feeds
Email Alerts
Search